Physician profile
Dylan Lawrence
NPI 1952960239
$13,849.06
in general payments reported to CMS, 2019-2025
8 companies · $8,549 in 2025
The $8,549 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.21 · 2023: $77.43 · 2024: $5,208 · 2025: $8,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $2,503 · Travel and Lodging: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $2,503.48 |
| Travel and Lodging | $1,330.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,781.96 | 2024-2025 | Journey II, Legion Revision, Redapt |
| Stryker Corporation | $1,412.95 | 2023-2025 | Mako, Profyle, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $240.10 | 2024-2025 | G7 |
| Omnilife Science, INC | $142.46 | 2025 | |
| Depuy Synthes Sales INC. | $139.21 | 2025 | Na, Tfn-Advance |
| Innovation Technologies INC | $55.02 | 2022-2023 | Irrisept |
| Orthalign INC | $42.20 | 2025 | Orthalign Plus |
| Medtronic, INC. | $35.16 | 2024 | Prestige Lp Cervical Disc System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.